Physician profile
Neetal Kumar
NPI 1942886973
$1,189.19
in general payments reported to CMS, 2019-2025
16 companies · $432 in 2025
The $432 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $176 · 2023: $304 · 2024: $278 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,013.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $433.95 | 2023-2025 | |
| Boston Scientific Corporation | $198.50 | 2025 | Exalt Model D, Spyglass, Overstitch Endoscopic Suturing System |
| Takeda Pharmaceuticals U.S.A., INC. | $148.66 | 2022-2025 | Gattex |
| Actelion Pharmaceuticals US, INC. | $57.59 | 2025 | Uptravi |
| Pfizer INC. | $55.27 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.49 | 2023-2024 | |
| Edwards Lifesciences Corporation | $37.08 | 2022 | |
| Amgen INC. | $34.73 | 2024 | |
| Janssen Biotech, INC. | $32.16 | 2025 | Tremfya, Stelara |
| Regeneron Healthcare Solutions, INC. | $22.48 | 2025 | Libtayo |
| Horizon Therapeutics Plc | $22.23 | 2022 | |
| Gilead Sciences, INC. | $19.88 | 2024 | Livdelzi |
| Travere Therapeutics, INC. | $19.46 | 2023 | |
| Celltrion USA INC. | $18.58 | 2024 | Vegzelma |
| Exact Sciences Corporation | $17.59 | 2023 | Cologuard Collection Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $17.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neetal Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.